LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
12.73
+0.43 (3.50%)
Jan 30, 2026, 4:00 PM EST - Market closed
LENSAR Market Cap
LENSAR has a market cap or net worth of $152.05 million as of February 2, 2026. Its market cap has increased by 61.22% in one year.
Market Cap
152.05M
Enterprise Value
138.07M
1-Year Change
61.22%
Ranking
Category
Stock Price
$12.73
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $152.05M, an increase of 94.92%. That is a compound annual growth rate of 13.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 152.05M | 9.46% |
| Dec 31, 2025 | 138.92M | 33.78% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Micro Biosystems | 196.35M |
| Nano-X Imaging | 188.94M |
| CVRx, Inc. | 179.54M |
| InfuSystem Holdings | 167.98M |
| Apyx Medical | 164.94M |
| Lucid Diagnostics | 163.84M |
| Inogen | 160.18M |
| Treace Medical Concepts | 147.83M |